Erik A. Imel
- Nephrology top 0.1%
- Parathyroid Disorders and Treatments 66
- Nutrition and Dietetics top 0.5%
- Magnesium in Health and Disease 19
- Rheumatology top 1%
- Heterotopic Ossification and Related Conditions 7
- Genetics top 1%
- Genetic Syndromes and Imprinting 16
- Connective tissue disorders research 6
- Oncology top 2%
- Bone health and treatments 36
-
- Medical Imaging and Pathology Studies 18
-
- Bone Metabolism and Diseases 7
- Co-authors
- Michael J. EconsThomas O. CarpenterKarl InsognaSiu L. HuiMunro PeacockSuzanne M. Jan de BeurIngrid A. HolmShoji Ichikawa
- Journals
- New England Journal of Medicine (1 paper)JAMA (1 paper)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Erik A. Imel
95 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Nephrology 3.3k
- Nutrition and Dietetics 940
- Rheumatology 884
- Genetics 1.3k
- Oncology 1.1k
Countries citing papers authored by Erik A. Imel
This map shows the geographic impact of Erik A. Imel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Imel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Imel more than expected).
Fields of papers citing papers by Erik A. Imel
This network shows the impact of papers produced by Erik A. Imel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Imel. The network helps show where Erik A. Imel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erik A. Imel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 10 | |
| 7 | 2021 | 53 | |
| 8 | 2021 | 27 | |
| 9 | FGF23 and Associated Disorders of Phosphate Wasting | 2019 | 30 |
| 10 | Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients | 2019 | 0 |
| 11 | Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia | 2016 | 1 |
| 12 | Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients | 2015 | 6 |
| 13 | 2015 | 7 | |
| 14 | 2015 | 114 | |
| 15 | 2015 | 20 | |
| 16 | Assessment of Quality of Life Data After 4 Monthly S.C. Doses of a Human Monoclonal Anti-Fibroblast Growth Factor 23 Antibody (KRN23) in Adults with X-linked Hypophosphatemia | 2014 | 1 |
| 17 | 2011 | 219 | |
| 18 | 2010 | 111 | |
| 19 | 2010 | 75 | |
| 20 | 2007 | 336 |
About Erik A. Imel
Erik A. Imel is a scholar working on Nephrology, Nutrition and Dietetics and Oncology, having authored 100 papers that have together received 4.2k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (66 papers), Bone health and treatments (36 papers), Magnesium in Health and Disease (19 papers), Medical Imaging and Pathology Studies (18 papers), Genetic Syndromes and Imprinting (16 papers), Heterotopic Ossification and Related Conditions (7 papers), Bone Metabolism and Diseases (7 papers) and Connective tissue disorders research (6 papers). The work is most often cited by research in Nephrology (3.3k citations), Nutrition and Dietetics (940 citations) and Rheumatology (884 citations). Erik A. Imel has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Michael J. Econs, Thomas O. Carpenter, Karl Insogna, Siu L. Hui, Munro Peacock, Suzanne M. Jan de Beur, Ingrid A. Holm, Shoji Ichikawa, Andrea H. Sorenson and Alison Skrinar. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.